Revenue segments as reported by the company.

Smokeable Products

Oral Tobacco Products

Wine

All Other

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Marketing, administration and research costs

Asset impairment and exit costs

Amortization of intangibles

General corporate expenses

Corporate asset impairment and exit costs

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Altria

Altria Group, Inc. operates as a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral tobacco products, and Wine. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral tobacco products segment is primarily moist smokeless tobacco products (MSTs) through brands like Copenhagen and Skoal as well as on! oral nicotine pouches sold by Helix. The Wine segment, through subsidiary Ste. Michelle Wine Estates Ltd, produces Washington State wines, primarily Chateau Ste. Michelle and 14 Hands, and owns wineries in or distributes wines from several other wine regions. The company was founded in 1919 and is headquartered in Richmond, VA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Altria reports robust Q4 earnings, focuses on innovation and growth

Altria's Q4 2022 performance reflects resilience amidst industry challenges, with a focus on innovation and shareholder returns. The company's strategic initiatives in smoke-free products and digital engagement underscore its commitment to long-term growth and harm reduction.

Altria reports resilient Q1 performance amid industry challenges and opportunities

Altria's Q1 2023 earnings call highlighted strong performance amidst industry challenges, emphasizing harm reduction and regulatory compliance. The company faces hurdles from inflation, regulatory changes, and evolving consumer behaviors, while focusing on growth opportunities in smoke-free products and strategic investments.

Altria reports solid Q2 earnings, eyes e-vapor growth opportunities

Altria's focus on smoke-free products and NJOY acquisition driving growth.
Challenges in the cigarette industry due to economic pressures and flavor bans.
Opportunities in the e-vapor category and expansion plans in the U.S.
Strong balance sheet and significant capital returns to shareholders.

Altria reports growth in earnings, navigates regulatory challenges in e-vapor

Altria's Q3 2023 earnings call highlighted solid financial performance, strategic focus on e-vapor products, and efforts to combat illegal vape products. The company faces challenges from regulatory uncertainties and illicit products but sees opportunities in expanding NJOY's reach and addressing market gaps.

Altria reports growth in smoke-free products amidst regulatory challenges

Altria's Q4 2023 earnings call highlighted growth in adjusted EPS, strategic focus on smoke-free products, and efforts to combat illicit e-vapor products. The company faces challenges in competitive segments and economic pressures but sees opportunities in new product introductions and regulatory collaborations.

Altria reports mixed Q1 performance, focuses on growth strategies

Altria's Q1 performance showed growth in NJOY and oral tobacco segments, with challenges in EPS decline and economic pressures on consumers.
Strengths include reaffirmed EPS guidance, strategic investments, and focus on combating illicit e-vapor products.
Opportunities lie in maximizing profitability in oral tobacco, product positioning, and capturing transitioning consumers.
Overall, Altria's performance reflects a mix of growth, challenges, and strategic opportunities in navigating market dynamics.

Altria's NJOY drives growth as company navigates e-vapor challenges

Altria's Q2 2024 earnings call showcased strong performance in smoke-free products, highlighting growth in retail share and volume momentum. Despite challenges in the e-vapor category, the company remains focused on responsible regulation and enforcement. With a commitment to shareholder value and long-term growth strategies, Altria is poised for continued success.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Altria Group, Inc. is a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral Tobacco Products, and All Other. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA, and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral Tobacco Products segment includes MST and snus products manufactured and sold by USSTC, and oral nicotine pouches manufactured and sold by Helix. The All Other segment refers to the financial results of NJOY, Helix ROW, and the IQOS System heated tobacco business. The company was founded in 1919 and is headquartered in Richmond, VA.

In the closing of the recent trading day, Altria (MO) stood at $50.63, denoting a +0.25% change from the preceding trading day.

Altria (MO) Advances While Market Declines: Some Information for Investors

Main Street Capital

Dividend growth stocks may not be the most exciting, but over the long term, all the dividend increases can really add up to meaningful cash flow in the later years. Every month we screen through for potential dividend growers looking for dividend safety, growth potential and consistent dividend payers. This month, we have three income favorites, one of which we haven't touched on since early 2022, and two new names to look at.

September's 5 Dividend Growth Stocks With 5.11%+ Yields

B&G Foods

Walgreens

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.

Wall Street's Most Accurate Analysts Weigh In On 3 Defensive Stocks With Over 7% Dividend Yields

Recently, Zacks.com users have been paying close attention to Altria (MO). This makes it worthwhile to examine what the stock has in store.

Altria Group, Inc. (MO) Is a Trending Stock: Facts to Know Before Betting on It

Blackstone Group

Canadian Natural Resources

Energy Transfer LP Unit

L3Harris

MPLX

Realty Income Corp

ONEOK

Philip Morris

Raytheon Technologies

Vici Properties

The Fed's rate cuts could trigger a rotation from bonds to dividend stocks, as investors seek alternatives for stable, attractive income. High-quality dividend stocks, particularly those offering inflation protection, are well-positioned to outperform in this shifting market. Investors should focus on selecting robust dividend stocks to build portfolios that provide income and capitalize on these macroeconomic changes.

Buy High-Quality Dividends Before It's Too Late - And 11 Picks Worth Considering

Crown Castle International

Healthpeak Properties Inc

Ford Motor Company

Kinder Morgan

Verizon

24/7 Wall St. Insights: Quality S&P 500 dividend stocks will be in demand as rates are lowered.

Grab the 6 Highest-Yielding S&P 500 Stocks Before Interest Rates Are Slashed

Archer-Daniels-Midland Company

Black Hills

California Water Service Group

Emerson Electric

Fortis

Genuine Parts

Hormel Foods

Coca-Cola

Kenvue

Leggett & Platt

Middlesex Water

National Fuel Gas

Northwest Natural Gas

PPG Industries

Stepan

SJW Group

Stanley Black & Decker

Target

United Bankshares

Universal Corp

"What is a Dividend King? A stock with 50 or more consecutive years of dividend increases.” - suredividend.com. The 53 Dividend Kings, screened as of Sept. 10, represented eight of 11 Morningstar Sectors. Broker-targeted top 10 net gains ranged around 11.59%-35.94%, topped by Emerson and Stephan. By yield, Altria tops all. Top 10 September dogs: HRL, KVUE, FRT, FTS, UBSI, BKH, NWN, CDUAF, UVV, and MO averaged 4.70% in yield.

Buy 7 September Dividend Kings, Watch 9 More

Altria stock is undervalued based on my dividend discount model valuation. Despite the firm's declining sales in recent years, this trend can stabilize as the tobacco market grows and especially as smoke-free products become a bigger piece of revenue pie. Buybacks can continue to improve per-share revenue and other per-share metrics, which tell a different story than non-per-share metrics.

Altria Stock: Still Smoking Hot Despite Declining Sales

Altria Group's 7.5% dividend yield is already enough to make many investors fall in love. However, its cash dividend yield understates its return potential drastically. Its total shareholder yield can be irresistible.

Altria: 7%+ Dividend Yield Is Good, 10%+ Total Shareholder Yield Is Irresistible

Amgen

Bank of Nova Scotia

CVS Health

International Paper

Pfizer

Stellantis N.V. 

Buy Low, Sell High, Get Paid To Wait: Our simple investment philosophy focuses on purchasing assets at a discount to their intrinsic value. Key factors for maximizing profit include industry growth, management quality, and buying at a discount to value. Dividends from companies with good management and growing cash flows help determine value relative to historical norms.

Buy Low, Sell High, Get Paid To Wait (5 Easy Examples)

Deere & Company

Dover

Federal Realty Investment Trust

Illinois Tool Works

Lockheed Martin

McDonald's

Microsoft

Nordson

Starbucks

Texas Instruments

We anticipate six dividend increases in September 2024, based on the consistent history of these blue-chip stocks announcing annual increases in this month. Dividend growth is crucial for financial freedom, especially in 2024 with high inflation, making undervalued dividend stocks with increasing dividends essential. We focus on a company's history of consecutive annual dividend increases and its five-year average dividend growth rate for our stock purchase decisions.

Dividend Increases Expected In September 2024

Altria bought NJOY and plugged the company's vaping product into its distribution network. NJOY is enjoying a huge boost in sales, leading to enthusiasm among investors.

NJOY Is Thriving, but Altria Needs More Than Vaping Before Investors Buy the Stock

British American Tobacco

Enbridge

Enterprise Products Partners

TC Energy

Market volatility has returned, with Nvidia plunging 9.5% in a single day. This highlights the extreme valuations and potential for significant market shifts. While big tech isn't likely a bubble, the growth-to-value rotation could continue, making ultra-high-yield aristocrats red-hot Wall Street darlings. Ultra-yield aristocrats offer attractive valuations and high yields, benefiting from potential rate cuts and market sentiment shifts, making them compelling buys.

Buy These 6 Ultra High Yielding Dividend Aristocrats Before It's Too Late

Automatic Data Processing

Apollo Global Management

Brookfield Asset Management

Franklin Resources

Essential Properties Realty Trust Inc

Federated Hermes

Paychex

SEI Investments

T. Rowe Price Group

Joel Greenblatt's Magic Formula combines value and quality investing. By focusing on earnings yield and return on capital, it has achieved 40% annual returns for 21 years. The market's recent selloff, driven by weak manufacturing data, is an opportunity to buy high-quality undervalued dividend blue-chip stocks using Joel Greenblatt's Magic Formula. September's market volatility is average. Focus on long-term investment strategies rather than knee-jerk reactions to short-term data.

10 Dividend Blue-Chip Bargains To Potentially Profit From This Irrational Market Freakout

News for Altria Stock (MO)